SpeeDx进一步扩大SARS-CoV-2基因分型系列试剂的检测范围

2021-10-11 国际文传网络

关键突变检测试剂的快速开发持续促进至关重要的研究和监测活动

创新分子诊断解决方案开发商SpeeDx Pty. Ltd.已进一步扩大其用于COVID-19变异株分析的研究试剂产品线，加入了与SARS-CoV-2拉姆达关注变异株(VOI)相关的一种关键的特征性突变。PlexPrime® SARS-CoV-2基因分型*产品线采用该公司的独家通用底物方法和获得专利的多路复用技术，自7月上市以来迅速扩大。该产品套件可单独或联合使用，用于支持对重大SARS-CoV-2关注或关切变异株的实验室研究和监测工作。

SpeeDx临床事务高级副总裁Charles Cartwright博士表示：“使用基于PCR的方法快速筛查阳性样本使实验室能在突变传播时轻松进行监测。我们的基因分型试剂套件锁定的单个突变经过精心挑选，以代表关键的谱系分化，因此我们发现，即便是最新出现的关注和关切变异株也能被我们现有产品阵容锁定，以进行进一步分析。”

PlexPrime® SARS-CoV-2 L452Q拉姆达*是一种单孔混合物，旨在检测C.37关注变异株（拉姆达）中发现的SARS-CoV-2的L452Q棘蛋白突变¹，以及SARS-CoV-2的RdRp基因靶点。该试剂是PlexPrime® SARS-CoV-2基因分型产品阵容中的第三款产品，能用作独立反射或与PlexPrime® SARS-CoV-2阿尔法/贝塔/伽马+和/或PlexPrime®P681R德尔塔试剂联合使用。PlexPrime® SARS-CoV-2基因分型与标准qPCR和液体处理仪器兼容，将减少目前开展高容量序列分析的实验室的支出和手工步骤。

参考文献

《追踪SARS-CoV-2变异株》。世界卫生组织。网址： https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

PlexPrime® SARS-CoV-2 L452Q拉姆达*是一种单孔混合物，旨在检测C.37关注变异株（拉姆达）中发现的SARS-CoV-2的L452Q棘蛋白突变1，以及SARS-CoV-2的RdRp基因靶点。该试剂是PlexPrime® SARS-CoV-2基因分型产品阵容中的第三款产品，能用作独立反射或与PlexPrime® SARS-CoV-2阿尔法/贝塔/伽马+和/或PlexPrime®P681R德尔塔试剂联合使用。（照片：美国商业资讯）

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1938045, encodeId=45681938045b2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Mar 05 19:07:05 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729145, encodeId=cfaa1e29145e1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 19 09:07:05 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321313, encodeId=48f2132131360, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486254, encodeId=6d2b1486254ba, content=<a href='/topic/show?id=084a41694c4' target=_blank style='color:#2F92EE;'>#基因分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41694, encryptionId=084a41694c4, topicName=基因分型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5c38095280, createdName=LShY0906_98743846, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
2022-03-05 hukaixun

#SARS-CoV#

24 0
[GetPortalCommentsPageByObjectIdResponse(id=1938045, encodeId=45681938045b2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Mar 05 19:07:05 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729145, encodeId=cfaa1e29145e1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 19 09:07:05 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321313, encodeId=48f2132131360, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486254, encodeId=6d2b1486254ba, content=<a href='/topic/show?id=084a41694c4' target=_blank style='color:#2F92EE;'>#基因分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41694, encryptionId=084a41694c4, topicName=基因分型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5c38095280, createdName=LShY0906_98743846, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
2022-06-19 feather89

#PE#

36 0
[GetPortalCommentsPageByObjectIdResponse(id=1938045, encodeId=45681938045b2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Mar 05 19:07:05 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729145, encodeId=cfaa1e29145e1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 19 09:07:05 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321313, encodeId=48f2132131360, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486254, encodeId=6d2b1486254ba, content=<a href='/topic/show?id=084a41694c4' target=_blank style='color:#2F92EE;'>#基因分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41694, encryptionId=084a41694c4, topicName=基因分型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5c38095280, createdName=LShY0906_98743846, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
2021-10-13 小刀医生

#SARS#

29 0
[GetPortalCommentsPageByObjectIdResponse(id=1938045, encodeId=45681938045b2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Mar 05 19:07:05 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729145, encodeId=cfaa1e29145e1, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 19 09:07:05 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321313, encodeId=48f2132131360, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486254, encodeId=6d2b1486254ba, content=<a href='/topic/show?id=084a41694c4' target=_blank style='color:#2F92EE;'>#基因分型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41694, encryptionId=084a41694c4, topicName=基因分型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5c38095280, createdName=LShY0906_98743846, createdTime=Wed Oct 13 03:07:05 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
2021-10-13 LShY0906_98743846

#基因分型#

42 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

报道

SpeeDx进一步扩大SARS-CoV-2基因分型系列试剂的检测范围

相关资讯

拓展阅读

科室

工具

服务